Kestra Medical (KMTS) Director Elizabeth Kwo Sells 4,010 Shares

What Happened

• Elizabeth Kwo, a director of Kestra Medical Technologies, sold 4,010 shares on September 21, 2026. The disposition was reported at a weighted average price of $24.26 per share, for total proceeds of approximately $97,268.
• The filing notes this sale was a nondiscretionary "sell-to-cover" transaction to satisfy tax withholding obligations tied to the vesting and settlement of restricted stock units (RSUs), so it was a routine tax-related sale rather than a discretionary market-timing sale.

Key Details

• Transaction date: 2026-09-21; Form 4 filed: 2026-09-23 (filed within the Form 4 reporting window).
• Shares sold: 4,010; weighted average price: $24.26; sale proceeds ≈ $97,268.
• Reported price range: $24.22–$24.32 (the $24.26 figure is a weighted average; reporting person can provide per-price breakdown on request).
• Reason (footnote): F1 — nondiscretionary sell-to-cover to satisfy tax withholding on RSU settlement; F2 — weighted-average price disclosure and range.
• Shares owned after the transaction: not specified in the provided excerpt of the filing.

Context

• Sell-to-cover transactions are common when RSUs vest and typically reflect tax withholding needs rather than a director's view on the company. Purchases are generally more informative as a positive signal; this transaction appears procedural.